technology
OpenAI acquires Orchestra Bio to coordinate drug-development work
OpenAI says it will combine Orchestra Bio’s drug-development coordination platform with Rosalind, its AI tools for life-sciences research. The planned agents are intended to help teams track studies, timelines and decisions across drug programmes.